Bernardo Herrera‐Imbroda

1.2k total citations
29 papers, 547 citations indexed

About

Bernardo Herrera‐Imbroda is a scholar working on Urology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bernardo Herrera‐Imbroda has authored 29 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Urology, 14 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bernardo Herrera‐Imbroda's work include Urological Disorders and Treatments (11 papers), Pelvic floor disorders treatments (6 papers) and Prostate Cancer Treatment and Research (6 papers). Bernardo Herrera‐Imbroda is often cited by papers focused on Urological Disorders and Treatments (11 papers), Pelvic floor disorders treatments (6 papers) and Prostate Cancer Treatment and Research (6 papers). Bernardo Herrera‐Imbroda collaborates with scholars based in Spain, Germany and France. Bernardo Herrera‐Imbroda's co-authors include M. Fernanda Lara, Isabel M. Aragón, María Isabel Queipo‐Ortuño, Gözde Yücel, Jaime Gómez‐Millán, Ander Izeta, Melanie L. Hart, Karl‐Dietrich Sievert, Bastian Amend and Jan E. Brinchmann and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Bernardo Herrera‐Imbroda

25 papers receiving 535 citations

Peers

Bernardo Herrera‐Imbroda

UROLO

RHEUM

SURGE

EPIDE

Alin Adrian Cumpănaş Romania

Carlos Arroyo Mexico

Johannes Eberle Austria

H R Jenkins United Kingdom

Rachel S. Edlin United States

Marco Levancini Italy

Serdar Arısan Türkiye

Minal Kumari India

D. A. R. de Berker United Kingdom

Raymond T. Foster United States

Alin Adrian Cumpănaş Romania

Bernardo Herrera‐Imbroda

219 ×1.1

UROLO

136 ×0.7

RHEUM

86 ×0.5

SURGE

36 ×0.2

EPIDE

121 ×0.9

Citations per year, relative to Bernardo Herrera‐Imbroda Bernardo Herrera‐Imbroda (= 1×) peers Alin Adrian Cumpănaş

Countries citing papers authored by Bernardo Herrera‐Imbroda

Since Specialization

Citations

This map shows the geographic impact of Bernardo Herrera‐Imbroda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernardo Herrera‐Imbroda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernardo Herrera‐Imbroda more than expected).

Fields of papers citing papers by Bernardo Herrera‐Imbroda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernardo Herrera‐Imbroda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernardo Herrera‐Imbroda. The network helps show where Bernardo Herrera‐Imbroda may publish in the future.

Co-authorship network of co-authors of Bernardo Herrera‐Imbroda

This figure shows the co-authorship network connecting the top 25 collaborators of Bernardo Herrera‐Imbroda. A scholar is included among the top collaborators of Bernardo Herrera‐Imbroda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernardo Herrera‐Imbroda. Bernardo Herrera‐Imbroda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Necchi, Andrea, Félix Guerrero‐Ramos, Paul L. Crispen, et al.. (2025). TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial. The Lancet Oncology. 26(10). 1312–1322.

Tombal, Bertrand, F. Gómez-Veiga, Á. Gómez-Ferrer, et al.. (2024). A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). European Urology Oncology. 7(5). 1051–1060. 5 indexed citations

Álvarez, Martina, et al.. (2024). The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer. Diagnostics. 14(22). 2501–2501. 3 indexed citations

Matas-Rico, Elisa, et al.. (2024). New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine. Cancers. 16(4). 803–803. 8 indexed citations

Olmos, David, David Lorente, Daniel Alameda, et al.. (2024). Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes. Annals of Oncology. 35(5). 458–472. 38 indexed citations

Herrera‐Imbroda, Bernardo, et al.. (2024). Bulbar urethroplasty techniques and stricture recurrence: differences between end-to-end urethroplasty versus the use of graft. Minerva Urology and Nephrology. 76(5). 563–569.

Tombal, Bertrand, F. Gómez-Veiga, Á. Gómez-Ferrer, et al.. (2023). A phase 2 randomized open-label study of oral darolutamide monotherapy vs. androgen deprivation therapy in men with hormone-naive prostate cancer (EORTC-GUCG 1532).. Journal of Clinical Oncology. 41(6_suppl). 160–160. 1 indexed citations

Herrera‐Imbroda, Bernardo, et al.. (2020). Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia. Oncology. 98(3). 161–167. 37 indexed citations

Goicoechea, María, Isabel M. Aragón, Bernardo Herrera‐Imbroda, et al.. (2019). Isolation and characterization of myogenic precursor cells from human cremaster muscle. Scientific Reports. 9(1). 3454–3454. 9 indexed citations

10.

Herrera‐Imbroda, Bernardo, et al.. (2018). Cell Therapy Clinical Trials for Stress Urinary Incontinence: Current Status and Perspectives. International Journal of Medical Sciences. 15(3). 195–204. 36 indexed citations

11.

Aragón, Isabel M., et al.. (2017). Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation. Urology. 108. 52–58. 18 indexed citations

12.

Aragón, Isabel M., Bernardo Herrera‐Imbroda, María Isabel Queipo‐Ortuño, et al.. (2016). The Urinary Tract Microbiome in Health and Disease. European Urology Focus. 4(1). 128–138. 212 indexed citations

13.

Herrera‐Imbroda, Bernardo, Mercedes Clemente‐Postigo, Juan Alcaide‐Torres, et al.. (2016). PDE5A Polymorphisms Influence on Sildenafil Treatment Success. The Journal of Sexual Medicine. 13(7). 1104–1110. 8 indexed citations

14.

Hart, Melanie L., Ander Izeta, Bernardo Herrera‐Imbroda, Bastian Amend, & Jan E. Brinchmann. (2015). Cell Therapy for Stress Urinary Incontinence. Tissue Engineering Part B Reviews. 21(4). 365–376. 42 indexed citations

15.

Herrera‐Imbroda, Bernardo, M. Fernanda Lara, Ander Izeta, Karl‐Dietrich Sievert, & Melanie L. Hart. (2014). Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter. Advanced Drug Delivery Reviews. 82-83. 106–116. 43 indexed citations

16.

Herrera‐Imbroda, Bernardo, et al.. (2012). Injertos vasculares por vía transperineal. ACTUALIDAD MEDICA. 97(787). 32–36.

17.

Herrera‐Imbroda, Bernardo, et al.. (2012). Urogenital Sinus Cyst in a 21-Year-Old Man. Archives of Sexual Behavior. 41(4). 1065–1068. 1 indexed citations

18.

Herrera‐Imbroda, Bernardo, et al.. (2011). The use of botulinum toxin in benign prostatic hyperplasia. Neurourology and Urodynamics. 31(1). 86–92. 13 indexed citations

19.

Herrera‐Imbroda, Bernardo, et al.. (2011). Percutaneous Tibial Nerve Stimulation in Treatment of Overactive Bladder: When Should Retreatment Be Started?. Urology. 78(5). 1046–1050. 23 indexed citations

20.

Herrera‐Imbroda, Bernardo, et al.. (2010). Uretroplastia dorsal según técnica de Barbagli: Análisis de resultados y factores de éxito. Archivos Españoles de Urología. 63(7). 537–44. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact